Avid Bioservices Inc (CDMO)

[tech0200]

Excellent post.
Many on this board have pointed that management is to blame for the miserable pps. How can you have small biotechs in phase II with a much less valuable pipeline cutting multi-billion dollars deals and have a much higher market cap that PPHM and not blame management at the same time?

Yes management should get praised for salvaging the botched phase II trial, the two recent collaborations that add much validation to Bavi, a phase III trial out of botched trial, AVID and the patents. But it all happened without any pps appreciation for which management is to blame. Management has scared off many would be investors and ticked off many shareholders some of which have been invested and investing for more than ten years. with a much less valuable pipeline